Vir Biotechnology Market Sentiment

Vir Biotechnology Inc

VIRNASDAQ

Trade with Public

$11.00

-0.30-2.65%

마지막 업데이트: Nov 2, 5:59 PM

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

실적: Q3 2026 실적이 내일 수 11월 4th에 시장 마감 후 발표됩니다.

컨퍼런스 콜: 내일 4:30 오후에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

Vir Biotechnology Market Sentiment - Benzinga

Vir Biotechnology Market Sentiment

Market sentiment signals for Vir Biotechnology (VIR): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 10.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

12 analysts

Options Flow (P/C)

—

Avg Consensus PT

$21

+88.3%

Highest Price Target

$31

+181.6%

Barclays

Lowest Price Target

$12

+9.0%

Raymond James

Short Interest

10.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 7, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+99.8%	$20 → $22	Maintained	Buy
Jun 11, 2026	Morgan Stanley	Michelle Gilson—	+145.2%	$23 → $27	Maintained	Overweight
Jun 3, 2026	Leerink Partners	Roanna Ruiz—	+90.7%	$20 → $21	Maintained	Outperform
Mar 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+81.7%	$15 → $20	Maintained	Buy
Feb 25, 2026	Barclays	Etzer Darout—	+172.5%	$26 → $30	Maintained	Overweight
Feb 24, 2026	Morgan Stanley	Michelle Gilson—	+118.0%	$20 → $24	Maintained	Overweight
Feb 24, 2026	Evercore ISI Group	Cory Kasimov—	+63.5%	$12 → $18	Maintained	Outperform
Feb 24, 2026	Needham	Joseph Stringer—	+63.5%	$14 → $18	Maintained	Buy
Feb 9, 2026	Needham	Joseph Stringer—	+27.2%	$14 → $14	Maintained	Buy
Dec 30, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+36.2%	$15 → $15	Maintained	Buy
Sep 15, 2025	HC Wainwright & Co.	Patrick R. Trucchio—	+36.2%	$15 → $15	Maintained	Buy
Sep 3, 2025	Evercore ISI Group	Cory Kasimov—	+9.0%	$12	Initiate	Outperform
Aug 27, 2025	B of A Securities	Geoff Meacham—	+27.2%	$12 → $14	Upgrade	Neutral→Buy
Jul 11, 2025	Raymond James	Sean McCutcheon—	+9.0%	$12	Initiate	Outperform
May 22, 2025	Needham	Joseph Stringer—	+27.2%	$14 → $14	Maintained	Buy
May 12, 2025	Needham	Joseph Stringer—	+27.2%	$19 → $14	Maintained	Buy
Apr 17, 2025	Goldman Sachs	Paul Choi—	+90.7%	$28 → $21	Maintained	Buy
Feb 28, 2025	Barclays	Gena Wang—	+181.6%	$26 → $31	Maintained	Overweight
Feb 28, 2025	HC Wainwright & Co.	Patrick Trucchio—	+899.1%	$110 → $110	Maintained	Buy
Feb 27, 2025	Needham	Joseph Stringer—	+72.6%	$19 → $19	Maintained	Buy
Jan 31, 2025	HC Wainwright & Co.	Patrick Trucchio—	+899.1%	$110 → $110	Maintained	Buy
Jan 13, 2025	Leerink Partners	Roanna Ruiz—	+81.7%	$18 → $20	Maintained	Outperform
Jan 10, 2025	HC Wainwright & Co.	Patrick Trucchio—	+899.1%	$110 → $110	Maintained	Buy
Jan 9, 2025	Morgan Stanley	Michelle Gilson—	+81.7%	$10 → $20	Upgrade	Equal-Weight→Overweight
Jan 9, 2025	JP Morgan	Eric Joseph—	+27.2%	$10 → $14	Maintained	Neutral